Evidence map›Paper›PMID 24044779›Full record

ArticleJournal of translational medicine2013

Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

Amin El-Heliebi, Thomas Kroneis, Evelyn Zöhrer, Johannes Haybaeck, Katja Fischereder, Karin Kampel-Kettner, Richard Zigeuner, Hannelore Pock, Regina Riedl, Rudolf Stauber and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Rare Cell Population Analysis in Early-Stage Breast Cancer Patients.Breast cancer : basic and clinical research · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. CTC analysis: an update on technological progress.Translational research : the journal of laboratory and clinical medicine · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Amin El-HeliebiInstitute of Pathology, Medical University of Graz, Auenbruggerplatz 25, Graz, 8036, Austria. karoline.lackner@medunigraz.at.
Thomas Kroneis
Evelyn Zöhrer
Johannes Haybaeck
Katja Fischereder
Karin Kampel-Kettner
Richard Zigeuner
Hannelore Pock
Regina Riedl
Rudolf Stauber
Jochen Bernd Geigl
Berthold Huppertz
Peter Sedlmayr
Carolin Lackner
Medical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle circulating tumor cells (CTCs) or circulating tumor microemboli (CTMs) are potential biomarkers of renal cell cancer (RCC), however studies of CTCs/CTMs in RCC are limited. In this pilot study we aimed to evaluate a novel blood filtration technique suited for cytomorphological classification, immunocytochemical and molecular characterization of filtered, so called circulating non-hematologic cells (CNHCs) - putative CTCs/CTMs - in patients with RCC.

methodsBlood of 40 patients with renal tumors was subjected to ScreenCell filtration. CNHCs were classified according to cytomorphological criteria. Immunocytochemical analysis was performed with antibodies against CD45, CD31 and carbonic anhydrase IX (CAIX, a RCC marker). DNA of selected CNHCs and respective primary tumors was analysed by array-CGH.

resultsCNHC-clusters with malignant or uncertain malignant cytomorphological features - putative CTMs - were negative for CD45, positive for CD31, while only 6% were CAIX positive. Array-CGH revealed that 83% of malignant and uncertain malignant cells did represent with a balanced genome whereas 17% presented genomic DNA imbalances which did not match the aberrations of the primary tumors. Putative single CTCs were negative for CD45, 33% were positive for CD31 and 56% were positive for CAIX.

conclusionsThe majority of CNHC-clusters, putative CTMs, retrieved by ScreenCell filtration may be of endothelial origin. Morphological criteria seem to be insufficient to distinguish malignant from non-malignant cells in renal cancer.

Indexed as

Cell ShapeAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Renal CellCase-Control StudiesCell CountCohort StudiesComparative Genomic HybridizationDNA, NeoplasmFemaleHumansImmunohistochemistryKidney NeoplasmsLaser Capture MicrodissectionBiomarkers, TumorDNA, NeoplasmPlatelet Endothelial Cell Adhesion Molecule-1

Identifiers

PMID24044779
PMCPMC3848446
OpenAlexW2138434640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.